D-dimer levels in type 1 and type 2 diabetic children and adolescents; relation to microvascular complications and dyslipidemia "own data and review"

Pediatric Endocrinology Reviews

Volumn 9, Issue 3, 2012, Pages 657-668

  El Asrar, Mohamed A ^a   Adly, Amira A M ^a   Hadidy, Eman S El ^a   Abdelwahab, Mahmoud A ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b Fayoum University   (Egypt)

Author keywords

Cholesterol; D dimer; Diabetes mellitus; Microvascular complications

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; D DIMER; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; FIBRINOLYSIS; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERCOAGULABILITY; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; BLOOD; CROSS-SECTIONAL STUDY; DIABETIC ANGIOPATHY; METABOLISM; MICROCIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DYSLIPIDEMIAS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MICROCIRCULATION;

EID: 84860795240     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. American Diabetes Association, Diabetes Care at Diabetes camps. Diabetes Care 2007;1:877-884
2. Aso Y, Matsumoto S, Fujiwara Y, Tayama K, Takebayashi K, lnukai T, Takemura Y Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: Association with increased plasminogen activator inhibitor-1. Metabolism 2002;51:471-476 (Pubitemid 34406564)
3. Ponder SW Type 2 diabetes in children and adolescents: «The family disease of the 21st century». Tex Med 2009;1(105):33-37
4. Wells PS, Anderson DR, Rodger M (2003) Evaluation of D-dimer in diagnosis of suspected deep -vein thrombosis. N Engl J Med 349:1227-1235 (Pubitemid 37152032)
5. Lowe GD, Yarnell JW, Rumley A, Bainton D, Sweetnam PM.C-Reactive Protein, Fibrin D-Dimer, and Incident Ischemic Heart Disease in the Speedwell Study : Are Inflammation and Fibrin Turnover Linked in Pathogenesis? Arterioscler Thromb Vasc Biol. 2001;21:603-610 (Pubitemid 32323395)
6. Cushman M, Lemaitre RN, Kuller LH, Psaty BM, Macy EM, Sharrett AR, Tracy RP. Fibrinolytic activation markers predict myocardial infarction in the elderly: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1999;19:493-498 (Pubitemid 29135146)
7. Lowe GD, Rumley A, McMahon AD, Ford I, O'Reilly DS, Packard CJ: lnterleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease. Arterioscler Thromb Vasc Biol 2004,24:1529-1534 (Pubitemid 39050452)
8. Legnani C, Palareti G, Cosmi B, Cini M, Tosetto A, and Tripodi A.Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study Haematologica June 2008;93:900-907; published ahead of print April 28, 2008, doi:10.3324/haematol.12320
9. Wells P, Anderson D, Rodger M, Forgie M, Kearon C, Dreyer J, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003;349:1227-1235 (Pubitemid 37152032)
10. Soheir S. Adam, Nigel S. Key, and Charles S. Greenberg. D-dimer antigen: current concepts and future prospects Blood 2009; 113:2878-2887
11. Curtin N, Highe G, Harris M, Braunstein A, Demattia F, Coss L. Extensive evaluation of the instrumentation laboratory IL test D-Dimer immunoturbidimetric assay on the ACL 9000 determines the D-Dimer cutoff value for reliable exclusion of venous thromboembolism. Lab Hematol 2004;10:88-94 (Pubitemid 38868032)
12. Kim Kl, Müller NL, Mayo JR . "Clinically suspected pulmonary embolism: utility of spiral CT". Radiology1999;210(3):693-697 (Pubitemid 29124029)
13. Stein PD, Hull RD, Patel KC, Olson RE, Ghali WA, Brant R, et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med. Apr 20 2004;140(8):589-602
14. Schutgens REG, Haas FJLM, Ruven HJT, Spannagl M, Horn K, Biesma DH. No influence of heparin plasma and other (pre)analytic variables on D-dimer determinations. Clin Chem 2002;48:1611-1613 (Pubitemid 34925808)
15. Shitrit D, Rudensky B, Zimran A, Elstein D. D-Dimer assay in Gaucher disease: correlation with severity of bone and lung involvement. Am J Hematol 2003;73:236-239 (Pubitemid 36898879)
16. Curtin N, Highe G, Harris M, Braunstein A, Demattia F, Coss L. Extensive evaluation of the instrumentation laboratory IL test D-Dimer immunoturbidimetric assay on the ACL 9000 determines the D-Dimer cutoff value for reliable exclusion of venous thromboembolism. Lab Hematol. 2004;10:88-94 (Pubitemid 38868032)
17. Schutgens R, Haas F, Gerritsen W, Van-der Horst F, Nieuwenhuis H, Biesma D. The usefulness of five D-dimer assays in the exclusion of deep venous thrombosis. J Thromb Haemost 2003;1:976-981
18. Wells P, Anderson D, Rodger M, Forgie M, Kearon C, Dreyer J, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003;349:1227-1235 (Pubitemid 37152032)
19. Shitrit D, Rudensky B, Zimran A, Elstein D. D-Dimer assay in Gaucher disease: correlation with severity of bone and lung involvement. Am J Hematol 2003;73:236-239 (Pubitemid 36898879)
20. Wieganda J, Kollerb M, Bingissera R. Does a negative D-dimer test rule out aortic dissection? Swiss Med Wkly 2007;137:462
21. Erem C, Hacihasanoǧlu A, Çelik S, Ovali E, Ersöz HO, Ukinç K, Deger O, Telatar M. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications. Med Princ Pract 2005;14(1):22-30
22. van Wersch JW, Donders SH, Westerhuis LW, Venekamp WJ (1991) Microalbuminuria in diabetic patients: relationship to lipid, glycometabolic, coagulation and fibrinolysis parameters. Eur J Clin Chem Clin Biochem 29: 493-498
23. Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Circulation 1995;91:284-290
24. World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva: WHO Department of Non communicable Disease Surveillance
25. Park JE, Park K (1979) Text book of preventive and social medicine, 7th edn. Hessers Barner side Ph Riblisher 1268, Napier Town
26. Sempe M, PedrongG, Roy-Ternot NP (1979) Auxologie le methods et sequences. Theraplix, Paris
27. Cole TJ, Freeman JV, Preece MA. Body mass index reference curves for the UK 1990. Arc Dis Child 1995;73(1):25-29
28. Tanner J M (1962) Growth at Adolescence, 2nd edn. Blackwell Scientific Publications, Oxford
29. National High Blood Pressure Education Program Working Group (NHBPEP) on High Blood Pressure in Children and Adotescents (2004) National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555-576
30. Tabaei B, Al-Kassab A, Zawaski C, Herman W. Does microalbuminuria predict diabetic nephropathy? Diabetic Care 2001;24(9):1560-1566 (Pubitemid 33716449)
31. Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P, Klingensmith GJ (2007) ISPAD Clinical Practice Consensus Guidelines 2006-2007 Assessment and monitoring of glycemie control in children and adolescents with diabetes. Pediatric Diabetes 8:408-418 (Pubitemid 350168157)
32. Tseng CH Differential dyslipidemia associated with Albuminuria in type 2 diabetic patients in Taiwan. Clin Biochem 2009;42:1019-1024
33. Wahlefeld AW Triglycerids determination after enzymatic hydrotysis. In: Bergmeyer HU (ed) Methods of enzymatic analysis 2nd edn. Academic Press, New York, 1974;1831-1835
34. Gallistl S, Sudi KM, Bokenstien M, Weinhandl G, Zotter H, Muntean W. Correlation between cholesterol, soluble P-selectin, and D-dimer in obese children and adolescents. Blood Coagulation and Fibrinolysis 2000;11(8):755-760 (Pubitemid 32010210)
35. Sommeijer DW, MacGillavry MR, Meijers JC, Van Zanten AP, Reitsma PH, Ten Cate H. Diabetes Care. Anti-inflammatory and anticoagulant effects of pravastatin in patients with type 2 diabetes. Diabetes Care. 2004;27(2):468-473 (Pubitemid 38174073)
36. Krishna P, Roopakola SM, Kumar KMP. Dyslipidemia in 947 type 1 diabetes mellitus in the young. Int J Diab Dev 2005;25(4):110-112
37. Perez A, Wagner AM, Carreras G, Gimenez G, Sanchez-Quesada JL, Rigla M, Gomez-Gerique JA, Pou JM, de Leiva A (2000) Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes metlitus: effect of glycemie control. Arch Intern Med 160(18):2756-2762
38. Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM, Eckardt K, Kaufman JM, Ryden M, Müller S, Hanisch FG, Ruige J, Arner P, Sell H, and Juergen Eckel J.Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome Diabetes published ahead of print May 18, 2011
39. Veiraiah A Hyperglycemia, lipoprotein glycation, and vascular disease. Angiology 2005;56(4):431-438 (Pubitemid 41040529)
40. Loredana Mareovecchio M, Neil Dalton R, Toby Prevost A, Acerini CL, Barrett TG, Cooper JD (2009) Pervalence of abnormal lipid profile and the relationship with the development of microalbu-minuria in adolescents with type 1 diabetes. Diabetes Care 32(4):658-663
41. Hayashibe H, Asayama K, Nakam T, Kobayahi K, Amemiya S, Nakazawa S. Decreased activity of plasma cholesteryl ester transfer protein in children and adolescent with insulino-dependent diabetes mellitus. Acta Paediatr 1999;88:1067-1070 (Pubitemid 29489160)
42. Igwe et al - Lipid profile of diabetes mellitus patients Nigerian Journal of Biochemistry and Molecular Biotogy 2008;23(1):25-29
43. Uttra KM, Devrajani B, Ali Shah SZ, Ti D, Das T, Raza S and Naseem. Lipid Profile of Patients with Diabetes mellitus(A Multidisciplinary Study. World Applied Sciences Journal 2011;12(9):1382-1384
44. Harley CR, Gandhi SK, Heien H et al, Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care. Expert Opin Pharmacother 2008;9:669-676 (Pubitemid 351566187)
45. Moss AJ, Goldstein RE, Marder VJ, Sparks CE, Oakes D, Greenberg H, Weiss HJ, Zareba W, Brown MW, Liang CS, Lichstein E, Little WC, Gillespie JA, Van Voorhees L, Krone RJ, Bodenheimer MM, Hochman J, Dwyer EM Jr, Arora R, Marcus FI, Watelet LF, Case RB. Thrombogenic factors and recurrent coronary events. Circulation 1999;99(19):2517-2522 (Pubitemid 29228281)
46. Sechi LA et al. Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension. Hypertension 2000;36:978-985
47. VaziriND, Smith DH, Winer RL, Weber MA, Gonzales EC, Neutel JM. Coagulation and inhibitory and fibrinolytic proteins in essential hypertension. .J Am Soc Nephrol. 1993;4(2):222-228
48. Mukha Al (2004) The content of D-dimer in peripheral blood as observed studied in thrombohemorrahagic lesions of the retina. Vestn Oftalmot 120(6):14-16
49. Long ZF, Qu GY, Xu M. Relationship between the level of plasma D-dimer and diabetic microangiopathy. Hunan Yi Ke Da Xue Xue Bao 2001;26(5):434-436
50. Harmanci A, Kandemir N, Dagdelen S, Gonc N, Buyukasik Y, Alikasifoglu A, Kirazli S, Ozon A, Gurlek A. Thrombin - activatable fibrinolysis inhibitor activity and global fibrinolytic capacity in type 1 diabetes: evidence for normal fibrinolytic state. J Diabetes Complications 2006;20:40-44 (Pubitemid 43028412)
51. Nwose EU, Richards RS, Jelinek HF, Kerr PG (2007) D-dimer identifies stages in progression of diabetes mellitus from family history of diabetes to cardiovascular comlications. Pathology 39(2):252-257 (Pubitemid 46439652)
52. Wakabayashi I, Masuda H. Association of D-dimer with microalbuminuria in patients with type 2 diabetes mellitus. J Thromb Thromblysis 2009;27:29-35
53. Loredana Mareovecchio M, Neil Dalton R, Toby Prevost A, Acerini CL, Barrett TG, Cooper JD. Pervalence of abnormal lipid profile and the relationship with the development of microalbu-minuria in adolescents with type 1 diabetes. Diabetes Care 2009;32(4):658-663
54. Wakabayashi I, Masuda H. Association of D-dimer with microalbuminuria in patients with type 2 diabetes mellitus. J Thromb Thromblysis 2009;27:29-35
55. Chang SS. Albuminuria and diabetic nephropathy. Pediatr Endocrinol Rev 2008;4:974-979
56. Tseng CH. Differential dyslipidemia associated with Albuminuria in type 2 diabetic patients in Taiwan. Clin Biochem 2009;42:1019-1024